SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-061486
Filing Date
2023-05-16
Accepted
2023-05-16 17:26:31
Documents
12
Period of Report
2023-05-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2315952d1_8k.htm   iXBRL 8-K 34203
  Complete submission text file 0001104659-23-061486.txt   210150

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20230516.xsd EX-101.SCH 3081
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20230516_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20230516_pre.xml EX-101.PRE 22627
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2315952d1_8k_htm.xml XML 3622
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 23928819
SIC: 2836 Biological Products, (No Diagnostic Substances)